viral hepatitis B

Fibrosis-4 index (FIB-4) scores are strongly associated with severe liver disease outcomes in a primary care population, both in patients with known chronic liver disease and those without known CLD. The result could help identify patients with CLD before their condition becomes severe. FIB-4 has previously shown utility in predicting the risk of advanced fibrosis